Wolverine Trading’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-274
Closed -$6.05K 5413
2023
Q3
$6.05K Buy
+274
New +$7.15K ﹤0.01% 4379
2022
Q4
Sell
-3
Closed -$1K 5306
2022
Q3
$1K Buy
+3
New +$1.97K ﹤0.01% 4490
2022
Q2
Sell
-5
Closed -$11K 6017
2022
Q1
$11K Sell
5
-5
-50% -$10.6K ﹤0.01% 5295
2021
Q4
$25K Sell
10
-1
-9% -$3.48K ﹤0.01% 5480
2021
Q3
$51K Buy
11
+5
+83% +$25.2K ﹤0.01% 6015
2021
Q2
$34K Sell
6
-3
-33% -$19.4K ﹤0.01% 5654
2021
Q1
$69K Buy
9
+6
+200% +$63.5K ﹤0.01% 5564
2020
Q4
$21K Buy
+3
New +$18.4K ﹤0.01% 4694
2019
Q4
Sell
-4
Closed -$56K 5369
2019
Q3
$56K Sell
4
-4
-50% -$32.1K ﹤0.01% 4029
2019
Q2
$70K Buy
8
+4
+100% +$46.9K ﹤0.01% 4119
2019
Q1
$49K Hold
4
﹤0.01% 4320
2018
Q4
$52K Sell
4
-4
-50% -$94K ﹤0.01% 4165
2018
Q3
$295K Buy
8
+5
+167% +$165K ﹤0.01% 3752
2018
Q2
$81K Hold
3
﹤0.01% 4792
2018
Q1
$81K Sell
3
-4
-57% -$108K ﹤0.01% 4792
2017
Q4
$138K Buy
+7
New +$145K ﹤0.01% 4345
2017
Q1
Sell
-6
Closed -$155K 5194
2016
Q4
$155K Sell
6
-1
-14% -$30.8K ﹤0.01% 3894
2016
Q3
$260K Buy
7
+5
+250% +$164K ﹤0.01% 3432
2016
Q2
$84K Buy
+2
New +$90.3K ﹤0.01% 3691

Other funds holding TTOO

Wolverine Trading's TTOO Position: Q4 2023 in Review

Wolverine Trading sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 300 shares — an estimated $6.63K sold.

Wolverine Trading first reported a position in TTOO in Q3 2017 and held it in 13 quarters. The position peaked at $96K in Q3 2018. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

  • Wolverine Trading reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
  • Wolverine Trading sold 300 T2 Biosystems, Inc shares in Q4 2023, an estimated $6.63K.
  • Wolverine Trading first reported a position in T2 Biosystems, Inc in Q3 2017 and held it in 13 quarters.
  • Wolverine Trading's T2 Biosystems, Inc position peaked at $96K in Q3 2018.
  • 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Wolverine Trading's 13F filing for Q4 2023, filed 14 Feb 2024.